Literature DB >> 16982144

Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys.

Andisheh Eslamboli1, Robert I Grundy, Elaine A Irving.   

Abstract

Nogo-A is a myelin-associated protein that has been shown to inhibit axonal sprouting after lesions to the CNS. Several studies have demonstrated that blocking the activity or expression of this inhibitor can induce structural and functional recovery after CNS lesions. However, there are limited and contradictory data on the expression of Nogo-A after CNS lesions. In the present study, marmoset monkeys received permanent occlusion of the middle cerebral artery (MCAo). Two, 3, or 4 months after the onset of injury brain sections were stained for Nogo-A protein. Two sham operated marmosets were included as a control. Nogo-A protein expression was quantified in white matter and grey matter in the areas adjacent to the lesion (or the equivalent areas in the intact side). At 2 months after injury, but not at 3 or 4 months, there was a significant increase in the number of oligodendrocytes that were Nogo-A immunopositive. This increase was observed in white matter structures that were adjacent to the lesion (e.g. corona radiate (CR)); but not in: white matter structures distal to the lesion (e.g. corpus callosum (CC)); cortical regions adjacent to the lesion; contralateral regions or in sham operated marmosets. These data suggest that Nogo-A levels are significantly increased within oligodendrocytes in areas adjacent to the lesion up to 2 months following cerebral ischaemia. Future studies will determine whether this offers the opportunity to promote plasticity by targeting Nogo-A weeks or months following stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982144     DOI: 10.1016/j.neulet.2006.08.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.

Authors:  J P Sarkey; M Chu; M McShane; E Bovo; Y Ait Mou; A V Zima; P P de Tombe; G L Kartje; J L Martin
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

2.  Nogo/RTN4 isoforms and RTN3 expression protect SH-SY5Y cells against multiple death insults.

Authors:  Felicia Yu Hsuan Teng; Bor Luen Tang
Journal:  Mol Cell Biochem       Date:  2013-08-18       Impact factor: 3.396

Review 3.  Therapeutics targeting Nogo-A hold promise for stroke restoration.

Authors:  Prateek Kumar; Lawrence D F Moon
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

4.  Nogo-A expression after focal ischemic stroke in the adult rat.

Authors:  Joseph L Cheatwood; April J Emerick; Martin E Schwab; Gwendolyn L Kartje
Journal:  Stroke       Date:  2008-05-08       Impact factor: 7.914

5.  A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators.

Authors:  Gabriella Smedfors; Lars Olson; Tobias E Karlsson
Journal:  Front Mol Neurosci       Date:  2018-02-19       Impact factor: 5.639

6.  NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats.

Authors:  Hong Zhao; Zhen-Dong Liu; Yong-Bo Zhang; Xiao-Yu Gao; Cui Wang; Yi Liu; Xun-Fen Wang
Journal:  Mol Med Rep       Date:  2021-10-13       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.